GHRP-2 dosage chart

Reconstitution steps

1. 1Draw 3.0 mL bacteriostatic water with a sterile syringe.
2. 2Inject slowly down the vial wall; avoid foaming.
3. 3Gently swirl or roll until completely dissolved (do not shake).
4. 4Label and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.

Important Notes

Practical considerations for consistency and safety.

• Use new sterile insulin syringes for each injection; dispose in a sharps container.
• Rotate injection sites (abdomen, thighs, upper arms) to reduce local irritation and prevent lipodystrophy.
• Very frequent dosing (e.g., every 2 hours) can cause progressive attenuation due to acute tachyphylaxis; once-daily administration avoids this issue.
• Multiple daily injections (2–3×) have been explored but require strict adherence and may offer limited added benefit.
• Document daily dose and site rotation to maintain consistency.

How This Works

GHRP-2 is a synthetic growth hormone secretagogue that binds to and activates ghrelin (GH secretagogue) receptors. This activation triggers potent, pulsatile release of growth hormone from the pituitary gland in a dose-dependent manner. Clinical studies in GH-deficient children demonstrated meaningful GH increases even at low doses (0.3–3.0 mcg/kg), with escalating doses over several months showing sustained efficacy. In healthy adults, doses of 100 mcg SC daily produce acute GH stimulation, while routine protocols typically maintain 100–300 mcg/day to balance efficacy with receptor sensitivity. The peptide has been well tolerated in clinical trials with no significant adverse effects or toxicity reported at these dosage ranges.

Potential Benefits & Side Effects

Observations from clinical and preclinical literature.

• Stimulates robust pulsatile GH release that may support favorable body composition changes and metabolic effects.
• In combination therapies (e.g., with GHRH analogs), can significantly increase IGF-1 levels when administered with perfect compliance.
• Generally well tolerated with placebo-like safety profile; transient side effects may include mild hunger sensation or flushing.
• Long-term therapy (8–24 months in GH-deficient subjects) has maintained positive effects on growth velocity with careful monitoring.
• Occasional mild injection-site reactions (redness, irritation) may occur with subcutaneous administration.

Lifestyle Factors

Complementary strategies for optimal outcomes.

• Maintain adequate protein intake and balanced nutrition to support the anabolic effects of elevated GH.
• Combine with resistance training to maximize body composition benefits.
• Prioritize sleep quality, as GH pulses naturally occur during deep sleep; evening administration may complement this rhythm.
• Manage stress effectively to support consistent adherence and recovery.
• Stay well hydrated to support metabolic processes.

Injection Technique

General subcutaneous guidance from clinical best-practice resources.

• Clean the vial rubber stopper and skin with alcohol swabs; allow to dry completely.
• Use a fine insulin syringe (typically 29–31 gauge, 0.5-inch needle).
• Pinch an inch of skin fat (abdomen, thigh, or outer upper arm); insert needle at 45° to 90° into subcutaneous tissue. (Use 90° angle if ample fatty tissue; 45° for leaner individuals to avoid intramuscular injection.)
• Do not aspirate for subcutaneous injections—aspiration is unnecessary and can cause needless tissue trauma.
• Inject slowly and steadily; wait a few seconds before withdrawing needle at same angle.
• Apply gentle pressure with swab if needed; do not massage or rub injection site.
• Rotate sites systematically to prevent irritation and lipodystrophy—space injections at least 1 inch apart.

important-note

This content is intended for therapeutic educational purposes only and does not constitute medical advice, diagnosis, or treatment.

GHRP-2 dosage FAQs